These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16175953)

  • 41. Pseudohyperkalemia: Look before you treat.
    De Rosales AR; Siripala DS; Bodana S; Ahmed F; Kumbala DR
    Saudi J Kidney Dis Transpl; 2017; 28(2):410-414. PubMed ID: 28352030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of splenectomy in myelofibrosis with myeloid metaplasia.
    Barugola G; Cavallini A; Lipari G; Armatura G; Mantovani W; Baggio E
    Minerva Chir; 2010 Dec; 65(6):619-25. PubMed ID: 21224796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Must we always treat hyperkalaemia?].
    Basile C; Manobianca G; Bruno A; Tamma F
    G Ital Nefrol; 2013; 30(1):. PubMed ID: 23832444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thrombocytosis and hyperkalemia].
    Eilertsen H; Ulveland K; Nerdrum HJ
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):512-3. PubMed ID: 10833946
    [No Abstract]   [Full Text] [Related]  

  • 45. A true MI?
    Sharma AK; Heist K; Russell G; Krahn T; Ferrell M
    Am J Med; 2011 Jul; 124(7):608-10. PubMed ID: 21531370
    [No Abstract]   [Full Text] [Related]  

  • 46. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia.
    Marvin KS; Spellberg RD
    Chest; 1993 Feb; 103(2):642-4. PubMed ID: 8432180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Haematological implications of splenectomy in myelofibrosis with myeloid metaplasia (author's transl)].
    Domingo Albos A; Pujol Moix N; Madoz Resano P; Cortada Font A; Diaz Cremades J; Algaba Arrea F; Nogueras FM
    Sangre (Barc); 1976; 21(3):451-60. PubMed ID: 968710
    [No Abstract]   [Full Text] [Related]  

  • 48. Factitious hyperkalemia in dogs with thrombocytosis. The effect of platelets on serum potassium concentration.
    Reimann KA; Knowlen GG; Tvedten HW
    J Vet Intern Med; 1989; 3(1):47-52. PubMed ID: 2926720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
    Lafaye F; Rain JD; Clot P; Najean Y
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver dysfunction following splenectomy in idiopathic myelofibrosis: a study of 10 patients.
    López-Guillermo A; Cervantes F; Bruguera M; Pereira A; Feliu E; Rozman C
    Acta Haematol; 1991; 85(4):184-8. PubMed ID: 1677228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombocytosis in splenic trauma: In-hospital course and association with venous thromboembolism.
    Chia TL; Chesney TR; Isa D; Mnatzakanian G; Colak E; Belmont C; Hirpara D; Veigas PV; Acuna SA; Rizoli S; Rezende-Neto J
    Injury; 2017 Jan; 48(1):142-147. PubMed ID: 27451291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can a 12-lead ECG be used to assess for hyperkalemia?
    Thompson C; Tsiperfal A
    Prog Cardiovasc Nurs; 2003; 18(2):112, 114. PubMed ID: 12732805
    [No Abstract]   [Full Text] [Related]  

  • 55. [Role of splenectomy in the treatment of myelofibrosis].
    Melikian AL; Kolosova LIu; Sokolova MA; Kovrigina AM; Silaev MA; Giliazitdinova EA; Gemdzhian ÉG; Karagiulian SR
    Ter Arkh; 2013; 85(8):69-76. PubMed ID: 24137967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Symptoms and causes of dyskalemia].
    Herbinger W
    Wien Med Wochenschr; 1968 Apr; 118(15):320-6. PubMed ID: 5726098
    [No Abstract]   [Full Text] [Related]  

  • 57. Pseudohyperkalemia, thrombocytosis and renal cancer.
    Pouthier D; Wilmart JF; Lamy S; Flath B; Humbel RL
    Clin Nephrol; 2001 Feb; 55(2):179-80. PubMed ID: 11269687
    [No Abstract]   [Full Text] [Related]  

  • 58. Markedly increased small-sized megakaryocytes and platelets count in the circulation with pseudo-hyperkalemia following splenectomy.
    Li G; Wang B; Li D; Zhu R; Chen X
    Eur J Med Res; 2022 Aug; 27(1):155. PubMed ID: 35999645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude.
    Sevastos N; Theodossiades G; Efstathiou S; Papatheodoridis GV; Manesis E; Archimandritis AJ
    J Lab Clin Med; 2006 Mar; 147(3):139-44. PubMed ID: 16503244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [On the diagnostic value of the electrocardiogram and the Achilles tendon reflex time in hyperkalemia].
    Saner R; Zentner P; Fankhauser S
    Schweiz Med Wochenschr; 1968 Aug; 98(31):1137-42. PubMed ID: 5705666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.